Andrew Last
Directeur des opérations chez BIO-RAD LABORATORIES, INC.
Fortune : 2 M $ au 30/06/2024
Profil
Andrew J. Last occupe le poste de directeur de l'exploitation et vice-président exécutif de Bio-Rad Laboratories, Inc. Le Dr. Last est également membre du conseil d'administration d'OncoCyte Corp. Auparavant, le Dr Last a occupé les postes de directeur de l'exploitation chez Precigen, Inc. et de vice-président du marketing mondial et de la planification stratégique chez Becton, Dickinson & Co. directeur général de PharMingen et vice-président du marketing mondial et stratégique chez BD Biosciences, Systems & Reagents, Inc. (toutes deux filiales de Becton, Dickinson & Co.), directeur commercial chez Berkeley Lights, Inc. et directeur de l'exploitation et vice-président exécutif chez Affymetrix, Inc. et vice-président exécutif chez Affymetrix, Inc. et vice-président et directeur général de l'activité d'expression génétique chez Applera Corp. et directeur de l'activité mondiale chez Monsanto Co. et directeur de l'activité maison et jardin chez The Solaris Group, et vice-président et directeur général chez Applied Biosystems, Inc. M. Last a obtenu un doctorat et un diplôme d'études supérieures de l'université de Cranfield et un diplôme de premier cycle de l'université de Leicester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/04/2024 | 5 720 ( 0,02% ) | 2 M $ | 30/06/2024 | |
ONCOCYTE CORPORATION
0,03% | 01/07/2024 | 3 509 ( 0,03% ) | 10 352 $ | 30/06/2024 |
Postes actifs de Andrew Last
| Sociétés | Poste | Début |
|---|---|---|
| ONCOCYTE CORPORATION | Directeur/Membre du Conseil | 23/12/2015 |
| BIO-RAD LABORATORIES, INC. | Directeur des opérations | 22/04/2019 |
CellChorus LLC
 CellChorus LLC BiotechnologyHealth Technology CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Andrew Last
| Sociétés | Poste | Fin |
|---|---|---|
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/04/2019 |
| PRECIGEN, INC. | Directeur des opérations | 27/11/2017 |
| AFFYMETRIX, INC. | Directeur des opérations | 01/07/2016 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2010 |
PharMingen
 PharMingen BiotechnologyHealth Technology Part of Becton, Dickinson & Co., PharMingen is a company that manufactures antibodies and reagents for biological research. The company is based in San Diego, CA. PharMingen was acquired by Becton, Dickinson & Co. on May 19, 1997. | Corporate Officer/Principal | 01/01/2010 |
Formation de Andrew Last
| Cranfield University | Doctorate Degree |
| University of Leicester | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| BIO-RAD LABORATORIES, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Entreprise privées | 9 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
The Solaris Group
 The Solaris Group Chemicals: AgriculturalProcess Industries The Solaris Group is a private company based in New York, NY. The CEO of the company is Albert Constantine Bellas. | Process Industries |
PharMingen
PharMingen BiotechnologyHealth Technology Part of Becton, Dickinson & Co., PharMingen is a company that manufactures antibodies and reagents for biological research. The company is based in San Diego, CA. PharMingen was acquired by Becton, Dickinson & Co. on May 19, 1997. | Health Technology |
BD Biosciences, Systems & Reagents, Inc.
 BD Biosciences, Systems & Reagents, Inc. Pharmaceuticals: MajorHealth Technology BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA. | Health Technology |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Technology Services |
CellChorus LLC
CellChorus LLC BiotechnologyHealth Technology CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020. | Health Technology |
